These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 11501455)

  • 21. Sentinel lymph node biopsy in patients with operable breast cancer treated with neoadjuvant chemotherapy.
    Rebollo-Aguirre AC; Gallego-Peinado M; Menjón-Beltrán S; García-García J; Pastor-Pons E; Chamorro-Santos CE; Ramos-Font C; Salamanca-Ballesteros A; Llamas-Elvira JM; Olea-Serrano N
    Rev Esp Med Nucl Imagen Mol; 2012; 31(3):117-23. PubMed ID: 21676504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. One Step Nucleic Acid Amplification (OSNA) positive micrometastases and additional histopathological NSLN metastases: Results from a single institution over 53 months.
    Babar M; Madani R; Jackson P; Layer GT; Kissin MW; Irvine TE
    Surgeon; 2016 Apr; 14(2):76-81. PubMed ID: 25444440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The benefits and limitations of sentinel lymph node biopsy.
    Amersi F; Hansen NM
    Curr Treat Options Oncol; 2006 Mar; 7(2):141-51. PubMed ID: 16455025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases.
    Shen J; Gilcrease MZ; Babiera GV; Ross MI; Meric-Bernstam F; Feig BW; Kuerer HM; Francis A; Ames FC; Hunt KK
    Cancer; 2007 Apr; 109(7):1255-63. PubMed ID: 17330229
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trends in axillary treatment for breast cancer patients undergoing sentinel lymph node biopsy as determined by a questionnaire from the Japanese Breast Cancer Society.
    Imoto S; Yamauchi C; Komoike Y; Tsugawa K; Yotsumoto D; Wada N; Ueno T; Oba MS; Shien T; Sugae S; Tsuda H; Yoneyama K
    Breast Cancer; 2017 May; 24(3):427-432. PubMed ID: 27553957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Learning curves and certification for breast cancer lymphatic mapping.
    Bass SS; Cox CE; Reintgen DS
    Surg Oncol Clin N Am; 1999 Jul; 8(3):497-509. PubMed ID: 10448692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic accuracy of sentinel lymph node biopsy in axillary lymph nodes at the early stages of breast cancer.
    Pusina S
    Med Arch; 2013; 67(4):252-5. PubMed ID: 24520746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perinodal fibrosis developed after ultrasonography-guided core-needle biopsy of a contrast-enhanced ultrasound-detected sentinel axillary node interferes with subsequent surgical sentinel node dissection.
    Serquiz N; Moro L; Menossi CA; Almeida NR; Baccarin G; de Paiva Silva GR; Shinzato JY; Derchain S; Jales RM
    J Clin Ultrasound; 2019 Oct; 47(8):445-452. PubMed ID: 31359458
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sentinel lymph node biopsy using periareolar injection of radiocolloid for patients with neoadjuvant chemotherapy-treated breast carcinoma.
    Shimazu K; Tamaki Y; Taguchi T; Akazawa K; Inoue T; Noguchi S
    Cancer; 2004 Jun; 100(12):2555-61. PubMed ID: 15197796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sentinel lymph node biopsy as an alternative to routine axillary lymph node dissection in breast cancer patients.
    Noguchi M
    J Surg Oncol; 2001 Feb; 76(2):144-56. PubMed ID: 11223844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of lymphatic tumor burden on sentinel lymph node biopsy results.
    Wong SL; Edwards MJ; Chao C; Simpson D; McMasters KM
    Breast J; 2002; 8(4):192-8. PubMed ID: 12100110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of immunohistochemistry and multiple-level sectioning in sentinel lymph nodes from patients with breast cancer.
    Pargaonkar AS; Beissner RS; Snyder S; Speights VO
    Arch Pathol Lab Med; 2003 Jun; 127(6):701-5. PubMed ID: 12741893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival outcomes in node-negative breast cancer patients evaluated with complete axillary node dissection versus sentinel lymph node biopsy.
    Cox C; White L; Allred N; Meyers M; Dickson D; Dupont E; Cantor A; Ly Q; Dessureault S; King J; Nicosia S; Vrcel V; Diaz N
    Ann Surg Oncol; 2006 May; 13(5):708-11. PubMed ID: 16538416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histopathologic analysis of sentinel lymph nodes in breast carcinoma.
    Hsieh PP; Ho WL; Yeh DC; Liu TJ; Wu CC; Lin JH; Wang SJ
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Oct; 63(10):744-50. PubMed ID: 11076431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sentinel lymph node micrometastasis as a predictor of axillary tumor burden.
    Dabbs DJ; Fung M; Landsittel D; McManus K; Johnson R
    Breast J; 2004; 10(2):101-5. PubMed ID: 15009035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow-up study of 4008 procedures.
    Naik AM; Fey J; Gemignani M; Heerdt A; Montgomery L; Petrek J; Port E; Sacchini V; Sclafani L; VanZee K; Wagman R; Borgen PI; Cody HS
    Ann Surg; 2004 Sep; 240(3):462-8; discussion 468-71. PubMed ID: 15319717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical significance of the lymphoscintigraphy in the evaluation of non-axillary sentinel lymph node localization in breast cancer.
    Gherghe M; Bordea C; Blidaru A
    Chirurgia (Bucur); 2015; 110(1):26-32. PubMed ID: 25800312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The sentinel lymph node in cancer of the breast: clinical aspects].
    Rouzier R; Travagli JP; Atallah D; Delaloge S; Marsiglia H; Mathieu MC; Lumbroso J; Garbay JR
    Bull Cancer; 2003 Mar; 90(3):246-54. PubMed ID: 12801827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recommendation for axillary lymph node dissection in women with early breast cancer and sentinel node metastasis: A systematic review and meta-analysis of randomized controlled trials using the GRADE system.
    Huang TW; Kuo KN; Chen KH; Chen C; Hou WH; Lee WH; Chao TY; Tsai JT; Su CM; Huang MT; Tam KW
    Int J Surg; 2016 Oct; 34():73-80. PubMed ID: 27562691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and evaluation of axillary sentinel lymph nodes in patients with breast carcinoma treated with neoadjuvant chemotherapy.
    Cohen LF; Breslin TM; Kuerer HM; Ross MI; Hunt KK; Sahin AA
    Am J Surg Pathol; 2000 Sep; 24(9):1266-72. PubMed ID: 10976701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.